Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor microenvironment and cellular senescence: Understanding therapeutic resistance and harnessing strategies
Hanxin Liu, Huifang Zhao, Yu Sun
Seminars in Cancer Biology (2021) Vol. 86, pp. 769-781
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Unraveling tumor microenvironment of small-cell lung cancer: Implications for immunotherapy
Tian Li, Tianyun Qiao
Seminars in Cancer Biology (2022) Vol. 86, pp. 117-125
Closed Access | Times Cited: 89
Rutin is a potent senomorphic agent to target senescent cells and can improve chemotherapeutic efficacy
Hanxin Liu, Qixia Xu, Halidan Wufuer, et al.
Aging Cell (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 73
Tumor microenvironment targeted nano-drug delivery systems for multidrug resistant tumor therapy
Xinyue Shao, Xiaoling Zhao, Binghao Wang, et al.
Theranostics (2025) Vol. 15, Iss. 5, pp. 1689-1714
Open Access | Times Cited: 4
Exosomal EPHA2 derived from highly metastatic breast cancer cells promotes angiogenesis by activating the AMPK signaling pathway through Ephrin A1-EPHA2 forward signaling
Baoai Han, He Zhang, Ruinan Tian, et al.
Theranostics (2022) Vol. 12, Iss. 9, pp. 4127-4146
Open Access | Times Cited: 49
Nanomedicine Combats Drug Resistance in Lung Cancer
Xiuli Zheng, Xiao-Hai Song, Guonian Zhu, et al.
Advanced Materials (2023) Vol. 36, Iss. 3
Closed Access | Times Cited: 36
A senescence-based prognostic gene signature for colorectal cancer and identification of the role of SPP1-positive macrophages in tumor senescence
Sifei Yu, Mengdi Chen, Li‐Li Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 29
Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment
Fusheng Zhang, Junchen Guo, Shengmiao Yu, et al.
Cancer Communications (2024) Vol. 44, Iss. 9, pp. 929-966
Open Access | Times Cited: 14
Cytokines and soluble mediators as architects of tumor microenvironment reprogramming in cancer therapy
Suling Xu, Qing-Qing Wang, Wenxue Ma
Cytokine & Growth Factor Reviews (2024) Vol. 76, pp. 12-21
Closed Access | Times Cited: 12
Drug tolerant persister cell plasticity in cancer: A revolutionary strategy for more effective anticancer therapies
Jun He, Zejing Qiu, Jingjing Fan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Combination of PARP inhibitor and CDK4/6 inhibitor modulates cGAS/STING‐dependent therapy‐induced senescence and provides “one‐two punch” opportunity with anti‐PD‐L1 therapy in colorectal cancer
Tao Wang, Weizhen Liu, Qian Shen, et al.
Cancer Science (2023) Vol. 114, Iss. 11, pp. 4184-4201
Open Access | Times Cited: 18
Cell Survival, Death, and Proliferation in Senescent and Cancer Cells: the Role of (Poly)phenols
Vincenzo Sorrenti, Alessandro Buriani, Stefano Fortinguerra, et al.
Advances in Nutrition (2023) Vol. 14, Iss. 5, pp. 1111-1130
Open Access | Times Cited: 17
Spatiotemporal transformable nano-assembly for on-demand drug delivery to enhance anti-tumor immunotherapy
Chenglin Liang, Ge Zhang, Linlin Guo, et al.
Asian Journal of Pharmaceutical Sciences (2024) Vol. 19, Iss. 1, pp. 100888-100888
Open Access | Times Cited: 7
Targeting senescent cells to reshape the tumor microenvironment and improve anticancer efficacy
Birong Jiang, Wei Zhang, Xuguang Zhang, et al.
Seminars in Cancer Biology (2024) Vol. 101, pp. 58-73
Open Access | Times Cited: 7
Autophagy and senescence facilitate the development of antiestrogen resistance in ER positive breast cancer
Michael K. McGrath, Ali Abolhassani, Luke Guy, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 6
Immunomodulatory role of metalloproteinase ADAM17 in tumor development
Kai Wang, Zixue Xuan, Xiaoyan Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
The Emerging Role of Senotherapy in Cancer: A Comprehensive Review
Sarubala Malayaperumal, Francesco Marotta, Makalakshmi Murali Kumar, et al.
Clinics and Practice (2023) Vol. 13, Iss. 4, pp. 838-852
Open Access | Times Cited: 15
Past and Future Directions for Research on Cellular Senescence
Yi Zhu, Zacharias P. Anastasiadis, Jair Machado Espindola Netto, et al.
Cold Spring Harbor Perspectives in Medicine (2023) Vol. 14, Iss. 2, pp. a041205-a041205
Closed Access | Times Cited: 14
Modeling of senescence-related chemoresistance in ovarian cancer using data analysis and patient-derived organoids
Xintong Cai, Yanhong Li, Jianfeng Zheng, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 5
Advances in predictive biomarkers associated with immunotherapy in extensive-stage small cell lung cancer
Tong Chen, Mingzhao Wang, Yanchao Chen, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Cytokine-Induced Senescence in the Tumor Microenvironment and Its Effects on Anti-Tumor Immune Responses
Maximilian Rentschler, Heidi Braumüller, Priscilla S. Briquez, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1364-1364
Open Access | Times Cited: 21
Effects of senescence on the tumour microenvironment and response to therapy
Louise E. Reynolds, Seynab Maallin, Scott Haston, et al.
FEBS Journal (2023) Vol. 291, Iss. 11, pp. 2306-2319
Open Access | Times Cited: 13
A new perspective on prostate cancer treatment: the interplay between cellular senescence and treatment resistance
Mengyao Xu, Zhi-Yu Xia, Jian‐Xuan Sun, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Chemotherapy-induced cellular senescence promotes stemness of aggressive B-cell non-Hodgkin’s lymphoma via CCR7/ARHGAP18/IKBα signaling activation
Jiyu Wang, Qianshan Tao, Keke Huang, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e009356-e009356
Open Access
Pharmacological Modulation of Cellular Senescence: Implications for Breast Cancer Progression and Therapeutic Strategies
Jialing Xie, Xinxin Shu, Zilan-Xie, et al.
European Journal of Pharmacology (2025), pp. 177475-177475
Closed Access
Targeting the Senescent Tumor Microenvironment to Sensitize Immunotherapy
Wen Sun
Highlights in Science Engineering and Technology (2025) Vol. 139, pp. 260-271
Closed Access
Page 1 - Next Page

Scroll to top